Metabolomic and Lipidomic Analysis of Serum from Mice Exposed to an Internal Emitter, Cesium-137, Using a Shotgun LC-MSE Approach

被引:44
作者
Goudarzi, Maryam [1 ]
Weber, Waylon M. [2 ]
Mak, Tytus D. [3 ]
Chung, Juijung [1 ]
Doyle-Eisele, Melanie [2 ]
Melo, Dunstana R. [2 ]
Brenner, David J. [4 ]
Guilmette, Raymond A. [2 ]
Fornace, Albert J., Jr. [1 ,3 ]
机构
[1] Georgetown Univ, Washington, DC 20057 USA
[2] Lovelace Resp Res Inst, Albuquerque, NM 87108 USA
[3] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA
[4] Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA
关键词
mass spectrometry; UPLC-MSE; metabolomics; lipidomics; radiation; internal emitter; Cesium-137; RADIATION EXPOSURE; URINARY BIOMARKERS; GAMMA-RADIATION; IDENTIFICATION; WORKFLOW; MODELS; MOUSE; GENE; P53;
D O I
10.1021/pr500913n
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In this study ultra performance liquid chromatography (UPLC) coupled to time-of-flight mass spectrometry in the MSE mode was used for rapid and comprehensive analysis of metabolites in the serum of mice exposed to internal exposure by Cesium-137 (Cs-137). The effects of exposure to Cs-137 were studied at several time points after injection of (CsCl)-Cs-137 in mice. Over 1800 spectral features were detected in the serum of mice in positive and negative electrospray ionization modes combined. Detailed statistical analysis revealed that several metabolites associated with amino acid metabolism, fatty acid metabolism, and the TCA cycle were significantly perturbed in the serum of Cs-137-exposed mice compared with that of control mice. While metabolites associated with the TCA cycle and glycolysis increased in their serum abundances, fatty acids such as linoleic acid and palmitic acid were detected at lower levels in serum after Cs-137 exposure. Furthermore, phosphatidylcholines (PCs) were among the most perturbed ions in the serum of Cs-137-exposed mice. This is the first study on the effects of exposure by an internal emitter in serum using a UPLC-MSE approach. The results have put forth a panel of metabolites, which may serve as potential serum markers to Cs-137 exposure.
引用
收藏
页码:374 / 384
页数:11
相关论文
共 21 条
  • [1] Ionizing radiation-inducible apoptosis in the absence of p53 linked to transcription factor EGR-1
    Ahmed, MM
    Sells, SF
    Venkatasubbarao, K
    Fruitwala, SM
    Muthukkumar, S
    Harp, C
    Mohiuddin, M
    Rangnekar, VM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (52) : 33056 - 33061
  • [2] Amundson SA, 2000, RADIAT RES, V154, P342, DOI 10.1667/0033-7587(2000)154[0342:IOPMBI]2.0.CO
  • [3] 2
  • [4] ARTUSO M, 1995, ONCOGENE, V11, P1427
  • [5] Chegary M., 2009, BIOCHIM BIOPHYS ACTA, V1797, P806
  • [6] Multiple Biological Activities of Lactic Acid in Cancer: Influences on Tumor Growth, Angiogenesis and Metastasis
    Dhup, Suveera
    Dadhich, Rajesh Kumar
    Porporato, Paolo Ettore
    Sonveaux, Pierre
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (10) : 1319 - 1330
  • [7] Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835
  • [8] Radiation hazards in children - Lessons from Chernobyl, Three Mile Island and Fukushima
    Fushiki, Shinji
    [J]. BRAIN & DEVELOPMENT, 2013, 35 (03) : 220 - 227
  • [9] Development of Urinary Biomarkers for Internal Exposure by Cesium-137 Using a Metabolomics Approach in Mice
    Goudarzi, Maryam
    Weber, Waylon
    Mak, Tytus D.
    Chung, Juijung
    Doyle-Eisele, Melanie
    Melo, Dunstana
    Brenner, David J.
    Guilmette, Raymond A.
    Fornace, Albert J., Jr.
    [J]. RADIATION RESEARCH, 2014, 181 (01) : 54 - 64
  • [10] Mitochondrial Fission Induces Glycolytic Reprogramming in Cancer-Associated Myofibroblasts, Driving Stromal Lactate Production, and Early Tumor Growth
    Guido, Carmela
    Whitaker-Menezes, Diana
    Lin, Zhao
    Pestell, Richard G.
    Howell, Anthony
    Zimmers, Teresa A.
    Casimiro, Mathew C.
    Aquila, Saveria
    Ando', Sebastiano
    Martinez-Outschoorn, Ubaldo E.
    Sotgia, Federica
    Lisanti, Michael P.
    [J]. ONCOTARGET, 2012, 3 (08) : 798 - 810